Content - Volume 100, 100-year theme: Blistering skin disorders (Feb)

All articles

Bullous Drug Reactions
Maja Mockenhaupt
Bullous drug eruptions are infrequent, but because they pose a challenge both to affected patients and to treating physicians they are considered to be the most severe cutaneous adverse reactions (SCAR). It is important to recognize these conditions and to differentiate them from other clinical entities involving blister formation. There may be early signs and symptoms that indicate a severe bullo ...
Pages: 122-134
Abstract  HTML  PDF
Current Concepts of Dermatitis Herpetiformis
Teea Salmi, Kaisa Hervonen
Dermatitis herpetiformis (DH) is an autoimmune skin disease that causes itchy, blistering rash, typically on the elbows, knees and buttocks. DH and coeliac disease share the same genetic background, gluten-dependent enteropathy and antibody response against tissue transglutaminase. DH is currently considered a cutaneous manifestation of coeliac disease, and the prevailing hypothesis is that DH dev ...
Pages: 115-121
Abstract  HTML  PDF
Drug Development in Pemphigoid Diseases
Katja Bieber, Ralf J. Ludwig
Pemphigoid diseases are organ-specific autoimmune diseases of the skin and/or mucous membranes. They are caused by autoantibodies targeting adhesion molecules located at the dermal–epidermal junction. While the diagnostics of pemphigoid diseases and insights into their pathogenesis have improved significantly, the development of novel treatments that are effective and safe remains an unmet medic ...
Pages: 108-114
Abstract  HTML  PDF
Collagen XVII Processing and Blistering Skin Diseases
Wataru Nishie
Collagen XVII (COL17) is a hemidesmosomal transmembrane protein in the skin, which, in several autoimmune blistering skin diseases, may be targeted by autoantibodies. In addition, loss-of-function mutations in the COL17A1 gene induce a subtype of junctional epidermolysis bullosa. The extracellular domain of COL17 can be physiologically cleaved from the cell surface by ADAM family proteins in a pro ...
Pages: 102-107
Abstract  HTML  PDF
Skin Fragility: Perspectives on Evidence-based Therapies
Leena Bruckner-Tuderman
The term skin fragility disorders describes a group of conditions in which the structural integrity of the skin is compromised and its resistance to external shear forces diminished. Skin fragility can have different causes, ranging from genetic variations to inflammatory or physical phenomena. The genetic skin fragility disorders, collectively called epidermolysis bullosa, serve as a paradigm for ...
Pages: 94-101
Abstract  HTML  PDF
Complete BLISTERING theme
Pages: 94-134
Abstract  PDF